Inflammatory demyelinating diseases of the central nervous system information
Human disease
This article needs more reliable medical references for verification or relies too heavily on primary sources, specifically: It relies too heavily on primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed. Find sources: "Inflammatory demyelinating diseases of the central nervous system" – news · newspapers · books · scholar · JSTOR(June 2022)
This article may be confusing or unclear to readers. Please help clarify the article. There might be a discussion about this on the talk page.(July 2022) (Learn how and when to remove this message)
Inflammatory demyelinating diseases (IDDs), sometimes called Idiopathic (IIDDs) due to the unknown etiology of some of them, are a heterogenous group of demyelinating diseases - conditions that cause damage to myelin, the protective sheath of nerve fibers - that occur against the background of an acute or chronic inflammatory process.[1][2][3] IDDs share characteristics with and are often grouped together under Multiple Sclerosis. They are sometimes considered different diseases from Multiple Sclerosis,[4][5] but considered by others to form a spectrum differing only in terms of chronicity, severity, and clinical course.[6][7]
Multiple sclerosis for some people is a syndrome more than a single disease.[8] As of 2019, three auto-antibodies have been found in atypical MS giving birth to separate diseases: Anti-AQP4 diseases, Anti-MOG and Anti-NF spectrums.[9] A LHON-associated MS[10] has also been reported, and in addition there have been inconclusive reports of TNF-α blockers inducing demyelinating disorders.[11]
The subject is under intense research and the list of MS autoantibodies is expected to grow in the near future.[12][13][14]
^Höftberger R, Lassmann H (2018). "Inflammatory demyelinating diseases of the central nervous system". Neuropathology. Handbook of Clinical Neurology. Vol. 145. pp. 263–283. doi:10.1016/B978-0-12-802395-2.00019-5. ISBN 9780128023952. PMC 7149979. PMID 28987175.
^"Find out more about demyelinating diseases, including multiple sclerosis". Mayo Clinic. Retrieved 2022-06-23.
^Fontaine B (September 2001). "[Borderline forms of multiple sclerosis]". Revue Neurologique (in French). 157 (8-9 Pt 2): 929–934. PMID 11787357.
^Wingerchuk DM, Lucchinetti CF (June 2007). "Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis". Current Opinion in Neurology. 20 (3): 343–350. doi:10.1097/WCO.0b013e3280be58d8. PMID 17495631. S2CID 17386506.
^Poser CM, Brinar VV (October 2007). "Disseminated encephalomyelitis and multiple sclerosis: two different diseases - a critical review". Acta Neurologica Scandinavica. 116 (4): 201–206. doi:10.1111/j.1600-0404.2007.00902.x. PMID 17824894. S2CID 44411472.
^Weinshenke B, Miller D (1999-01-13). "Multiple sclerosis: one disease or many?". In Siva A, Kesselring J, Thompson AJ (eds.). Frontiers in Multiple Sclerosis, II. Taylor & Francis. pp. 37–46. ISBN 978-1-85317-506-0.
^Hartung HP, Grossman RI (May 2001). "ADEM: distinct disease or part of the MS spectrum?". Neurology. 56 (10): 1257–1260. doi:10.1212/WNL.56.10.1257. PMID 11376169. S2CID 219199163.
^Zabad RK, Stewart R, Healey KM (October 2017). "Pattern Recognition of the Multiple Sclerosis Syndrome". Brain Sciences. 7 (10): 138. doi:10.3390/brainsci7100138. PMC 5664065. PMID 29064441.
^Fujihara K (June 2019). "Neuromyelitis optica spectrum disorders: still evolving and broadening". Current Opinion in Neurology. 32 (3): 385–394. doi:10.1097/WCO.0000000000000694. PMC 6522202. PMID 30893099.
^Kemanetzoglou E, Andreadou E (2017). "CNS Demyelination with TNF-α Blockers". Current Neurology and Neuroscience Reports. 17 (4): 36. doi:10.1007/s11910-017-0742-1. ISSN 1528-4042. PMC 5364240. PMID 28337644.
^Lang K, Prüss H (September 2017). "Frequencies of neuronal autoantibodies in healthy controls: Estimation of disease specificity". Neurology. 4 (5): e386. doi:10.1212/NXI.0000000000000386. PMC 5515597. PMID 28761905.
^Kusunoki S (December 2013). "Autoantibodies in neuroimmunological diseases; relevance of fine specificity". Experimental Neurology. 250: 219–220. doi:10.1016/j.expneurol.2013.10.009. PMID 24120752. S2CID 45173537.
^Seay M, Galetta S (September 2018). "Glial Fibrillary Acidic Protein Antibody: Another Antibody in the Multiple Sclerosis Diagnostic Mix". Journal of Neuro-Ophthalmology. 38 (3): 281–284. doi:10.1097/WNO.0000000000000689. PMID 29923872. S2CID 49310332.
and 27 Related for: Inflammatory demyelinating diseases of the central nervous system information
Inflammatorydemyelinatingdiseases (IDDs), sometimes called Idiopathic (IIDDs) due to the unknown etiology of some of them, are a heterogenous group of...
Chronic inflammatorydemyelinating polyneuropathy (CIDP) is an acquired autoimmune diseaseofthe peripheral nervoussystem characterized by progressive...
A demyelinatingdisease refers to any disease affecting thenervoussystem where the myelin sheath surrounding neurons is damaged. This damage disrupts...
antibody disease (MOGAD) or MOG antibody-associated encephalomyelitis (MOG-EM) is an inflammatorydemyelinatingdiseaseofthecentralnervoussystem. Serum...
chronic debilitating demyelinatingdiseaseofthecentralnervoussystem, caused by an autoimmune attack resulting in the progressive loss of myelin sheath on...
to the particular type of polyneuropathy, and there are many different causes of each type, including inflammatorydiseases such as Lyme disease, vitamin...
Multiple sclerosis and other demyelinatingdiseasesofthecentralnervoussystem (CNS) produce lesions (demyelinated areas in the CNS) and glial scars or...
using the method of centrifugal sedimentation. This process is used for red blood cell diseases such as sickle cell crises or severe malaria. The automated...
as a type of MS. But NMO is a different condition. Other causes of TM include infections, immune system disorders, and demyelinatingdiseases. Viral infections...
found to upregulate inflammatory mediating molecules. Glial cells can effectively recognize pathogens in both thecentralnervoussystem and in peripheral...
In biology, thenervoussystem is the highly complex part of an animal that coordinates its actions and sensory information by transmitting signals to...
myelitis, chronic inflammatorydemyelinating polyneuropathy, Guillain–Barré syndrome, central pontine myelinosis, inherited demyelinatingdiseases such as leukodystrophy...
related to diseases (infectious or non-infectious) and medical disorders. Acronyms in healthcare List of medical abbreviations: Overview List of medical...
glycoprotein, a glycoprotein MOG antibody disease, an inflammatorydemyelinatingdiseaseofthecentralnervoussystem MOG (wine), material other than grapes...
normally control voluntary muscle contraction. ALS is the most common form ofthe motor neuron diseases. ALS often presents in its early stages with gradual...
(VWM disease) is an autosomal recessive neurological disease. The cause ofthedisease are mutations in any ofthe 5 genes encoding subunits ofthe translation...
(ADEM), or acute demyelinating encephalomyelitis, is a rare autoimmune disease marked by a sudden, widespread attack of inflammation in the brain and spinal...
change of glial cells in response to damage to thecentralnervoussystem (CNS). In most cases, gliosis involves the proliferation or hypertrophy of several...
the centralnervoussystem. Acute inflammation usually follows injury to thecentralnervoussystem immediately, and is characterized by inflammatory molecules...
Global Information
